PharmX Technologies Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was AUD 3.24 million compared to AUD 3.08 million a year ago. Net loss was AUD 1.73 million compared to AUD 0.571 million a year ago.

Basic loss per share was AUD 0.0029 compared to AUD 0.001 a year ago. Diluted loss per share was AUD 0.0029 compared to AUD 0.001 a year ago.